R. Ouedraogo

1.9k total citations · 1 hit paper
27 papers, 1.6k citations indexed

About

R. Ouedraogo is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, R. Ouedraogo has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Surgery. Recurrent topics in R. Ouedraogo's work include Pancreatic function and diabetes (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). R. Ouedraogo is often cited by papers focused on Pancreatic function and diabetes (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). R. Ouedraogo collaborates with scholars based in Belgium, United States and Australia. R. Ouedraogo's co-authors include Barry J. Goldstein, Kalyankar Mahadev, Annette L. Kirchgessner, Xiangdong Wu, Rosario Scalia, Peter A. McCue, Satish RamachandraRao, Gang Qiu, Yanqing Zhu and Hitomi Usui and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

R. Ouedraogo

25 papers receiving 1.5k citations

Hit Papers

Adiponectin regulates albuminuria and podocyte function i... 2008 2026 2014 2020 2008 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Ouedraogo Belgium 16 604 456 391 285 241 27 1.6k
Yasushi Teshima Japan 28 188 0.3× 1.1k 2.5× 503 1.3× 1.3k 4.4× 318 1.3× 98 2.8k
Philip Janiak France 22 148 0.2× 510 1.1× 271 0.7× 459 1.6× 423 1.8× 53 1.7k
Yoshiko Tokutomi Japan 21 123 0.2× 487 1.1× 392 1.0× 488 1.7× 279 1.2× 34 1.6k
Françoise Pecker France 20 456 0.8× 809 1.8× 196 0.5× 325 1.1× 206 0.9× 33 1.7k
Oksana Kunduzova France 23 140 0.2× 642 1.4× 297 0.8× 409 1.4× 529 2.2× 44 1.8k
S Angielski Poland 24 147 0.2× 997 2.2× 408 1.0× 213 0.7× 415 1.7× 145 2.3k
Gang Yuan China 17 355 0.6× 268 0.6× 312 0.8× 332 1.2× 157 0.7× 40 1.4k
Yuansheng Gao United States 27 145 0.2× 783 1.7× 1.1k 2.7× 612 2.1× 303 1.3× 92 2.5k
Lora C. Bailey‐Downs United States 14 145 0.2× 566 1.2× 371 0.9× 167 0.6× 110 0.5× 26 1.4k
Paul Schiffers Netherlands 21 79 0.1× 479 1.1× 414 1.1× 408 1.4× 195 0.8× 69 1.7k

Countries citing papers authored by R. Ouedraogo

Since Specialization
Citations

This map shows the geographic impact of R. Ouedraogo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ouedraogo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ouedraogo more than expected).

Fields of papers citing papers by R. Ouedraogo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ouedraogo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ouedraogo. The network helps show where R. Ouedraogo may publish in the future.

Co-authorship network of co-authors of R. Ouedraogo

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ouedraogo. A scholar is included among the top collaborators of R. Ouedraogo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ouedraogo. R. Ouedraogo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouedraogo, R., et al.. (2024). A mathematical model of plasmin-mediated fibrinolysis of single fibrin fibers. PLoS Computational Biology. 20(12). e1012684–e1012684.
3.
Mahadev, Kalyankar, et al.. (2008). Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovascular Research. 78(2). 376–384. 92 indexed citations
4.
Sharma, Kumar, Satish RamachandraRao, Gang Qiu, et al.. (2008). Adiponectin regulates albuminuria and podocyte function in mice. Journal of Clinical Investigation. 118(5). 1645–56. 498 indexed citations breakdown →
5.
Wu, Xiangdong, et al.. (2007). Adiponectin suppresses IκB kinase activation induced by tumor necrosis factor-α or high glucose in endothelial cells: role of cAMP and AMP kinase signaling. American Journal of Physiology-Endocrinology and Metabolism. 293(6). E1836–E1844. 62 indexed citations
6.
Ouedraogo, R., Xiangdong Wu, Shi‐Qiong Xu, et al.. (2006). Adiponectin Suppression of High-Glucose–Induced Reactive Oxygen Species in Vascular Endothelial Cells. Diabetes. 55(6). 1840–1846. 204 indexed citations
7.
Boverie, S., Marie‐Hélène Antoine, F. Somers, et al.. (2005). Effect onKATPChannel Activation Properties and Tissue Selectivity of the Nature of the Substituent in the 7- and the 3-Position of 4H-1,2,4-Benzothiadiazine 1,1-Dioxides. Journal of Medicinal Chemistry. 48(10). 3492–3503. 48 indexed citations
8.
Ouedraogo, R., Erik Näslund, & Annette L. Kirchgessner. (2003). Glucose Regulates the Release of Orexin-A From the Endocrine Pancreas. Diabetes. 52(1). 111–117. 100 indexed citations
9.
Antoine, Marie‐Hélène, et al.. (2002). In vitro and in vivo effects of new insulin releasing agents. Biochemical Pharmacology. 63(3). 515–521. 7 indexed citations
10.
Tong, Qingchun, R. Ouedraogo, & Annette L. Kirchgessner. (2002). Localization and function of group III metabotropic glutamate receptors in rat pancreatic islets. American Journal of Physiology-Endocrinology and Metabolism. 282(6). E1324–E1333. 58 indexed citations
11.
Ouedraogo, R., Benjamin De Becker, F. Somers, et al.. (2002). 2-Alkyl-3-Alkylamino-2H-Benzo- and Pyridothiadiazine 1,1-Dioxides: From K+ATP Channel Openers to Ca++ Channel Blockers?. Biological Chemistry. 383(11). 1759–68. 6 indexed citations
12.
Pereira, Frederico C., R. Ouedraogo, Philippe Lebrun, et al.. (2001). Insulinotropic Action of White Lupine Seeds (Lupinus albus L.): Effects on Ion Fluxes and Insulin Secretion from Isolated Pancreatic Islets. Biomedical Research. 22(2). 103–109. 14 indexed citations
13.
Ouedraogo, R., et al.. (2000). Effects of 3-Alkylamino-7-chloro-4<I>H</I>-pyrido[2,3-<I>e</I>]-1,2,4-thiadiazine 1,1-Dioxides on Smooth Muscle Contraction. Pharmacy and Pharmacology Communications. 6(2). 97–100. 5 indexed citations
15.
Ouedraogo, R., Marie‐Hélène Antoine, Cheikhou Kane, et al.. (1999). Insulinotropic Effect of New Glibenclamide Isosteres. Journal of Pharmacology and Experimental Therapeutics. 289(2). 625–631. 4 indexed citations
16.
Lebrun, Pierre, R. Ouedraogo, André Herchuelz, et al.. (1997). Pyridothiadiazines as Potent Inhibitors of Glucose-Induced Insulin Release. Advances in experimental medicine and biology. 426. 145–148. 2 indexed citations
17.
Antoine, Marie‐Hélène, et al.. (1997). 3-Morpholinosydnonimine as instigator of a glibenclamide-sensitive reduction in the insulin secretory rate. Biochemical Pharmacology. 53(8). 1211–1213. 5 indexed citations
18.
Lebrun, Philippe, R. Ouedraogo, Bernard Pirotte, et al.. (1997). Verapamil, a phenylalkylamine Ca 2 + channel blocker, inhibits ATP-sensitive K + channels in insulin-secreting cells from rats. Diabetologia. 40(12). 1403–1410. 15 indexed citations
19.
Antoine, Marie‐Hélène, et al.. (1996). Hydroxylamine, a nitric oxide donor, inhibits insulin release and activates K+ATP channels. European Journal of Pharmacology. 313(3). 229–235. 34 indexed citations
20.
Lebrun, Pierre, R. Ouedraogo, Cheikhou Kane, et al.. (1996). Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 156–162. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026